Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study

Open access

Abstract

RATIONALE: Standard therapeutic approaches to reduce social anxiety in autistic adults have limited effectiveness. Since 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy shows promise as a treatment for other anxiety disorders, a blinded, placebo-controlled pilot study was conducted. OBJECTIVES: To explore feasibility and safety of MDMA-assisted psychotherapy for reduction of social fear and avoidance that are common in the autistic population. METHODS: Autistic adults with marked to very severe social anxiety were randomized to receive MDMA (75 to 125 mg, n = 8) or inactive placebo (0 mg, n = 4) during two 8-h psychotherapy sessions (experimental sessions) in a controlled clinical setting. Double-blinded experimental sessions were spaced approximately 1 month apart with 3 non-drug psychotherapy sessions following each. The primary outcome was change in Leibowitz Social Anxiety Scale (LSAS) Total scores from Baseline to one month after the second experimental session. Outcomes were measured again six months after the last experimental session. RESULTS: Improvement in LSAS scores from baseline to the primary endpoint was significantly greater for MDMA group compared to the placebo group (P = 0.037), and placebo-subtracted Cohen's d effect size was very large (d = 1.4, CI - 0.074, 2.874). Change in LSAS scores from baseline to 6-month follow-up showed similar positive results (P = 0.036), with a Cohen's d effect size of 1.1 (CI - 0.307, 2.527). Social anxiety remained the same or continued to improve slightly for most participants in the MDMA group after completing the active treatment phase. CONCLUSIONS: This pilot trial demonstrated rapid and durable improvement in social anxiety symptoms in autistic adults following MDMA-assisted psychotherapy. Initial safety and efficacy outcomes support expansion of research into larger samples to further investigate this novel treatment for social anxiety. TRIAL REGISTRATION: clinicaltrials.gov identifier, NCT02008396.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-018-5010-9

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CONSORT diagram
Fig. 1 CONSORT diagramCC BY · PubMed Central
Fig. 2 Change over time in LSAS total scores (MDMA n = 8 at baseline, n = 7 at all other time points; placebo n = 4). The primary endpoint occurred 1 month after the second experimental session. The 6-month follow-up visit was 6 months after the primary endpoint. The MDMA group had a greater mean change from baseline than the placebo group at the primary endpoint (P = 0.037) and at the 6-month follow-up (P = 0.036). The line at LSAS score of 60 represents inclusion criteria minimum score
Fig. 2 Change over time in LSAS total scores (MDMA n = 8 at baseline, n = 7 at all other time points; placebo n = 4). The primary endpoint occurred 1 month after the second experimental session. The 6-month follow-up visit was 6 months after the primary endpoint. The MDMA group had a greater mean change from baseline than the placebo group at the primary endpoint (P = 0.037) and at the 6-month follow-up (P = 0.036). The line at LSAS score of 60 represents inclusion criteria minimum scoreCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 3

  1. Danforth A (2013) Courage, connection, clarity: a mixed-model, collective-case study of MDMA (ecstasy) experiences of autistic adults (doctoral dissertation). Retrieved from ProQuest Dissertations & Theses (PQDT) database. (UMI No. 3596826)
  2. First MB, Spitzer RL, Gibbon M, Williams JB (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, Patient edition. New York Psychiatric Institute, New York
  3. Kadel R, Kip KA (2012) SAS macro to compute effect size (Cohen’s d) and its confidence interval from raw survey data. In: Proceedings of the Annual Southeast SAS Users Group Conference

Cited by

See all 280

Metadata

Authors
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A.
Affiliations
  • The Lundquist Institute (US)
  • Harbor–UCLA Medical Center (US)
  • California Institute of Integral Studies (US)
Corresponding author
Grob, Charles S.
Venue
Psychopharmacology
Published
2018-09-08
Volume
235
Issue
11
Pages
3137-3148
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2892030583
Cited by
280
References
50
Citations by year
2026: 20 · 2025: 36 · 2024: 61 · 2023: 59 · 2022: 35 · 2021: 31 · 2020: 20 · 2019: 16
FWCI
19.64
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Psychopharmacology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Multidisciplinary Association for Psychedelic Studies (NA)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Social Psychology › Music Therapy and Health
Keywords
MDMA-assisted psychotherapy, social anxiety, autism spectrum disorder, autistic adults, treatment efficacy, treatment safety
MeSH terms
Adult, Anxiety, Autistic Disorder, Combined Modality Therapy, Double-Blind Method, Fear, Female, Humans, Male, Middle Aged, Pilot Projects, Psychotherapy, Treatment Outcome, Serotonin Agents, N-Methyl-3,4-methylenedioxyamphetamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. https://app.cochat.ai/papers/10.1007/s00213-018-5010-9
The paper
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology. https://doi.org/10.1007/s00213-018-5010-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.